XML 14 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover page - shares
9 Months Ended
Sep. 30, 2022
Nov. 07, 2022
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2022  
Document Transition Report false  
Entity File Number 001-37977  
Entity Registrant Name AVADEL PHARMACEUTICALS PLC  
Entity Incorporation, State or Country Code L2  
Entity Tax Identification Number 98-1341933  
Entity Address, Address Line One 10 Earlsfort Terrace  
Entity Address, City or Town Dublin 2  
Entity Address, Postal Zip Code D02 T380  
Entity Address, Country IE  
Country Region 353  
City Area Code 1  
Local Phone Number 901-5201  
Title of 12(b) Security Ordinary Shares, nominal value $0.01 per share**  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Smaller Reporting Company true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   61,778,732
Entity Central Index Key 0001012477  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Amendment Flag false  
No Trading Symbol true  
NASDAQ/NMS (GLOBAL MARKET)    
Entity Information [Line Items]    
Title of 12(b) Security American Depositary Shares*  
Trading Symbol AVDL  
Security Exchange Name NASDAQ